Jin Sun Lee

Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

Marius M. Hoeper, Hikmet Al‐Hiti, Raymond L. Benza et al. · The Lancet Respiratory Medicine · 2021 · 151 citations

Hypertension, Pulmonary Arterial Hypertension, Phosphodiesterase-5 Inhibitors +11

Clinical effect of imatinib added to intensive combination chemotherapy for newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia

KH Lee, Je‐Hwan Lee, S-J Choi et al. · Leukemia · 2005 · 149 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +7

Bone marrow vs extramedullary relapse of acute leukemia after allogeneic hematopoietic cell transplantation: risk factors and clinical course

KH Lee, Je‐Hwan Lee, S-J Choi et al. · Bone Marrow Transplantation · 2003 · 115 citations

Clinical Course, Hematological Malignancy, Transplantation +12

LBA14 Amivantamab plus lazertinib vs osimertinib as first-line treatment in patients with EGFR-mutated, advanced non-small cell lung cancer (NSCLC): Primary results from MARIPOSA, a phase III, global, randomized, controlled trial

B.C. Cho, Enriqueta Felip, Alexander I. Spira et al. · Annals of Oncology · 2023 · 83 citations · Full text

Lba14 Amivantamab, Medicine, Phase Iii +7

Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer

Yuan Yuan, Jin Sun Lee, Susan E. Yost et al. · European Journal of Cancer · 2021 · 82 citations · Full text